首页> 美国卫生研究院文献>AAPS PharmSciTech >Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release
【2h】

Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release

机译:羟丙基甲基纤维素对喷雾凝结聚乙二醇微粒中甲硝唑结晶度的影响及其对各种添加剂对甲硝唑释放的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to investigate the effect of a hydrophilic polymer, hydroxypropyl methylcellulose (HPMC), on the crystallinity and drug release of metronidazole (MNZ) in spray-congealed polyethylene glycol (PEG) microparticles and to further modify the drug release using other additives in the formulation. HPMC has been used in many pharmaceutical formulations and processes but to date, it has not been employed as an additive in spray congealing. Crystallinity of a drug is especially important to the development of pharmaceutical products as active pharmaceutical ingredients (APIs) are mostly crystalline in nature. A combination of X-ray diffractometry, differential scanning calorimetry, Raman spectroscopy and Fourier transform-infrared spectroscopy (FT-IR) spectroscopy was employed to investigate the degree of crystallinity and possible solid-state structure of MNZ in the microparticles. The microparticles with HPMC were generally spherical. Spray congealing decreased MNZ crystallinity, and the presence of HPMC reduced the drug crystallinity further. The reduction in MNZ crystallinity was dependent on the concentration of HPMC. Smaller HPMC particles also resulted in a greater percentage reduction in MNZ crystallinity. Appreciable modification to MNZ release could be obtained with HPMC. However, this was largely attributed to the role of HPMC in forming a diffusion barrier. Further modification of drug release from spray-congealed PEG-HPMC microparticles was achieved with the addition of 5% w/w dicalcium phosphate but not with magnesium stearate, methyl cellulose, polyvinylpyrrolidone, silicon dioxide and sodium oleate/citric acid. Dicalcium phosphate facilitated formation of the diffusion barrier.
机译:这项研究的目的是研究亲水聚合物羟丙基甲基纤维素(HPMC)对喷雾凝结的聚乙二醇(PEG)微粒中甲硝唑(MNZ)的结晶度和药物释放的影响,并进一步使用配方中的其他添加剂。 HPMC已用于许多药物制剂和工艺中,但迄今为止,尚未在喷雾凝结中用作添加剂。药物的结晶度对药物产品的开发尤为重要,因为活性药物成分(API)本质上大多是结晶的。将X射线衍射仪,差示扫描量热仪,拉曼光谱仪和傅里叶变换红外光谱仪(FT-IR)结合使用,以研究MNZ在微粒中的结晶度和可能的固态结构。具有HPMC的微粒通常是球形的。喷雾凝结降低了MNZ的结晶度,并且HPMC的存在进一步降低了药物的结晶度。 MNZ结晶度的降低取决于HPMC的浓度。较小的HPMC颗粒也导致MNZ结晶度降低的百分比更大。 HPMC可以对MNZ版本进行适当的修改。但是,这在很大程度上归因于HPMC在形成扩散阻挡层中的作用。通过添加5%w / w磷酸二钙,而不添加硬脂酸镁,甲基纤维素,聚乙烯吡咯烷酮,二氧化硅和油酸钠/柠檬酸,可以实现对喷雾凝结的PEG-HPMC微粒释放药物的进一步修饰。磷酸氢钙促进了扩散阻挡层的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号